IDEXX Laboratories Inc

IDEXX Laboratories Inc Stock Forecast & Price Prediction

Live IDEXX Laboratories Inc Stock (IDXX) Price
$551.21

7

Ratings

  • Buy 4
  • Hold 3
  • Sell 0
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price

$551.21

P/E Ratio

P/E Ratio not available for IDXX

Volume Traded Today

$418,999

Dividend

Dividends not available for IDXX

52 Week High/low

579.68/372.50

IDEXX Laboratories Inc Market Cap

$46.14B

🛑 Alert: These ten stocks could have higher potential than $IDXX 🛑

Before you buy IDXX you’ll want to see this list of ten stocks that have huge potential. Want to see if IDXX made the cut? Enter your email below

IDXX Summary

From what 7 stock analysts predict, the share price for IDEXX Laboratories Inc (IDXX) might increase by 10.79% in the next year. This is based on a 12-month average estimation for IDXX. Price targets go from $525.00 to $675.00. The majority of stock analysts believe IDXX is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

IDXX Analyst Ratings

IDXX is a stock in Health Care which has been forecasted to be worth $610.71 as an average. On the higher end, the forecast price is $675.00 USD by nathan rich from Goldman Sachs and on the lower end IDXX is forecasted to be $525.00 by david westenberg from Piper Sandler.

IDXX stock forecast by analyst

Analyst/Firm

Rating

Price Target

Change

Date

chris schott
J.P. Morgan

Buy

$630.0

maintained

Feb 6, 2024
jonathan block
Stifel Nicolaus

Hold

$570.0

rated

Feb 6, 2024
erin wright
Morgan Stanley

Buy

$620.0

maintained

Feb 6, 2024
michael ryskin
Bank of America Securities

Hold

$600.0

reiterated

Feb 5, 2024
balaji prasad
Barclays

Buy

$655.0

rated

Feb 5, 2024
nathan rich
Goldman Sachs

Buy

$675.0

reiterated

Feb 5, 2024
david westenberg
Piper Sandler

Hold

$525.0

downgraded

Jan 30, 2024
steve chesney
Atlantic Equities

Hold

$600.0

downgraded

Aug 2, 2023
elliot wilbur
Raymond James

Hold

None

maintained

Feb 6, 2023
jason goldberg
Barclays

Buy

$582.0

rated

Jan 16, 2023
andrew cooper
Raymond James

Hold

None

reiterated

Feb 2, 2021
rob eich
Cleveland Research

Hold

None

maintained

Apr 27, 2020
mark massaro
BTIG

Buy

$315.0

maintained

Oct 31, 2019
ryan daniels
William Blair

Buy

None

maintained

Oct 24, 2019
john ransom
Raymond James

Hold

None

maintained

Aug 17, 2018
nicholas jansen
Raymond James

Hold

None

maintained

Feb 6, 2018
derik de bruin
Bank of America Securities

Buy

$220.0

maintained

Feb 2, 2018
alexander nowak
Craig-Hallum

Buy

$211.0

maintained

Feb 1, 2018
kevin ellich
Craig-Hallum

Hold

$75.0

maintained

Feb 1, 2016
david clair
Piper Sandler

Hold

$126.0

rated

Jul 28, 2014

IDXX Company Information

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDXX
IDEXX Laboratories Inc (IDXX)

When did it IPO

1991

Staff Count

11,000

Country

United States

Sector/Industry

Healthcare/Diagnostics & Research

CEO

Mr. Jonathan J. Mazelsky

Market Cap

$46.14B

IDEXX Laboratories Inc(IDXX) Financial Data

In 2023, IDXX generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that IDXX's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2019

N/A

Revenue From 2020

N/A

0.00 %
From Previous Year

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year
  • Revenue TTM $3.66B
  • Operating Margin TTM 0.27%
  • Gross profit TTM $2.00B
  • Return on assets TTM 0.23%
  • Return on equity TTM 0.81%
  • Profit margin 0.23083%
  • Book value 17.87%
  • Market capitalisation $46.14B
  • Revenue for 2020 N/A
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • EPS this year 10.06
  • EPS next year N/A
... ...

Similar Stocks to IDEXX Laboratories Inc IDXX

🛑 Alert: These ten stocks could have higher potential than $IDXX 🛑

Before you buy IDXX you’ll want to see this list of ten stocks that have huge potential. Want to see if IDXX made the cut? Enter your email below

...

IDXX Frequently asked questions

The highest forecasted price for IDXX is $675.00 from nathan rich at Goldman Sachs.

The lowest forecasted price for IDXX is $525.00 from david westenberg from Piper Sandler

The IDXX analyst ratings consensus are 4 buy ratings, 3 hold ratings, and 0 sell ratings.